Sign in

CIK 0001395937

  • Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320162505
Phone
+1 781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2016-03-08 MPM BioVentures IV QP LP 10% owner Conversion +1,138,210 1,138,210
2016-03-08 MPM BioVentures IV QP LP 10% owner Conversion +718,396 1,856,606
2016-03-08 MPM BioVentures IV QP LP 10% owner Conversion +312,085 2,168,691
2016-03-08 MPM BioVentures IV QP LP 10% owner Conversion · Series A-1 Preferred Stock −1,138,210 0
2016-03-08 MPM BioVentures IV QP LP 10% owner Conversion · Series B-1 Preferred Stock −718,396 0
2016-03-08 MPM BioVentures IV QP LP 10% owner Conversion · Series C-1 Preferred Stock −312,085 0
2016-03-08 ROYSTON IVOR Director Conversion +315,195 315,195
2016-03-08 ROYSTON IVOR Director Conversion +198,931 514,126
2016-03-08 ROYSTON IVOR Director Conversion +86,419 600,545
2016-03-08 ROYSTON IVOR Director Purchase +150,000 $12.00 $1.8M 750,545
2016-03-08 ROYSTON IVOR Director Conversion · Series A-1 Preferred Stock −315,195 0
2016-03-08 ROYSTON IVOR Director Conversion · Series B-1 Preferred Stock −198,931 0
2016-03-08 ROYSTON IVOR Director Conversion · Series C-1 Preferred Stock −86,419 0
2016-03-08 EVNIN LUKE Director Conversion +1,138,210 1,138,210
2016-03-08 EVNIN LUKE Director Conversion +718,396 1,856,606
2016-03-08 EVNIN LUKE Director Conversion +312,085 2,168,691
2016-03-08 EVNIN LUKE Director Conversion · Series A-1 Preferred Stock −1,138,210 0
2016-03-08 EVNIN LUKE Director Conversion · Series B-1 Preferred Stock −718,396 0
2016-03-08 EVNIN LUKE Director Conversion · Series C-1 Preferred Stock −312,085 0
2016-03-08 DP VI Associates, L.P. Director Conversion +13,925 13,925

Page 27 of 28 · 550 trades